Pharmacyclics (PCYC +1%) moves higher in today's trading on an upgrade to Buy at TheStreet,...

|By:, SA News Editor

Pharmacyclics (PCYC +1%) moves higher in today's trading on an upgrade to Buy at TheStreet, citing the company's strong financials, "robust" revenue growth and a respectable return on equity.